FDA notifications. New guidance assists HIV drug development. Changes affect approvals for antiretroviral drugs.
The Food and Drug Administration has issued new guidance intended to assist sponsors in the clinical development of drugs for the treatment of HIV infection.
D019380:Anti-HIV Agents; D018791:CD4 Lymphocyte Count; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004352:Drug Resistance, Microbial; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration; D019562:Viral Load
D019380:Anti-HIV Agents